# Slovaquie – Antinéoplasiques et immunomodulateurs – Lieky ATC skupiny L01CD01, účinná látka Paklitaxel, parent nanočastice viazané na albumín 100 mg

Acheteur : Všeobecná zdravotná poisťovňa, a. s..  Pays : Slovaquie.

Source: QUOTA CÔTE — https://quotacote.com/opportunites/slovaquie-antineoplasiques-et-immunomodulateurs-lieky-atc-skupiny-l01c--76a0377e-d2b7-403c-aa20-98f40f804ced
Last checked by QUOTA: 2026-08-31
Methodology: https://quotacote.com/a-propos-des-donnees

## Key facts

- Country: Slovaquie [FACT]
- Deadline: 2026-09-14 [FACT]
- Last checked by QUOTA: 2026-08-31 [FACT]
- Sector (QUOTA normalisation): Autre [ANALYSIS]
- Summary: QUOTA editorial summary of the source notice [ANALYSIS]

## Entities

- geography: Slovaquie
- funder: Všeobecná zdravotná poisťovňa, a.s.
- buyer: Všeobecná zdravotná poisťovňa, a.s.

## Limitations

- QUOTA republishes a normalised summary, not the tender documents themselves.
- Commercial details (source dossier, full deadline history, budget) are reserved for subscribers.